Michael F Sharpnack et al.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 13(10), 1519-1529 (2018-07-19)
Despite apparently complete surgical resection, approximately half of resected early-stage lung cancer patients relapse and die of their disease. Adjuvant chemotherapy reduces this risk by only 5% to 8%. Thus, there is a need for better identifying who benefits from